Lonza to buy large-scale biologics Vacaville site from Roche for USD 1.2 billion
Basel: Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion. The acquisition will significantly increase Lonza’s large-scale biologics manufacturing capacity to meet demand for commercial mammalian contract manufacturing […]